227 related articles for article (PubMed ID: 18499417)
21. Modeling framework for human exposure assessment.
Jayjock MA; Chaisson CF; Arnold S; Dederick EJ
J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S81-9. PubMed ID: 17505502
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in the way forward for alternative methods: formation of national consensus platforms in Europe.
Rogiers V
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):408-13. PubMed ID: 16055162
[TBL] [Abstract][Full Text] [Related]
23. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
24. Alternative methods to safety studies in experimental animals.
Greim HA
Arch Toxicol; 2009 Jan; 83(1):5-7. PubMed ID: 19034432
[No Abstract] [Full Text] [Related]
25. Personal and static sample measurements are related.
Cherrie JW
Occup Environ Med; 2004 Apr; 61(4):374. PubMed ID: 15031401
[No Abstract] [Full Text] [Related]
26. Progress in applying the three Rs of Russell & Burch to the testing of biological products.
Balls M; Halder M
Dev Biol (Basel); 2002; 111():3-13. PubMed ID: 12678219
[TBL] [Abstract][Full Text] [Related]
27. The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies--implications for REACH.
Wells MY; Williams ES
Regul Toxicol Pharmacol; 2009 Mar; 53(2):150-5. PubMed ID: 19126422
[TBL] [Abstract][Full Text] [Related]
28. Letter to the editor: a regulatory view on the discussion on the role of alternative methods in the risk assessment of chemicals in the context of REACH.
Gundert-Remy U; Bernauer U; Madle S; Oberemm A; Schulte A; Richter-Reichhelm HB
Arch Toxicol; 2009 Jan; 83(1):9-10. PubMed ID: 19002668
[No Abstract] [Full Text] [Related]
29. Special issue of Inhalation Toxicology for air pollution and health: bridging the gap from sources-to-health outcomes. Preface.
Solomon PA
Inhal Toxicol; 2010 Dec; 22 Suppl 2():1-5. PubMed ID: 21142795
[No Abstract] [Full Text] [Related]
30. Alternatives to animal testing: current status and future perspectives.
Liebsch M; Grune B; Seiler A; Butzke D; Oelgeschläger M; Pirow R; Adler S; Riebeling C; Luch A
Arch Toxicol; 2011 Aug; 85(8):841-58. PubMed ID: 21607681
[TBL] [Abstract][Full Text] [Related]
31. Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S.
Becker RA; Borgert CJ; Webb S; Ansell J; Amundson S; Portier CJ; Goldberg A; Bruner LH; Rowan A; Curren RD; Stott WT
Regul Toxicol Pharmacol; 2006 Oct; 46(1):18-22. PubMed ID: 16876299
[TBL] [Abstract][Full Text] [Related]
32. Animal testing: more than a cosmetic change.
Abbott A
Nature; 2005 Nov; 438(7065):144-6. PubMed ID: 16281001
[No Abstract] [Full Text] [Related]
33. [Assessment of carcinogenicity of formaldehyde based on the newest literature data].
Kupczewska-Dobecka M
Med Pr; 2007; 58(6):527-39. PubMed ID: 18421935
[TBL] [Abstract][Full Text] [Related]
34. The INDEX project: executive summary of a European Union project on indoor air pollutants.
Koistinen K; Kotzias D; Kephalopoulos S; Schlitt C; Carrer P; Jantunen M; Kirchner S; McLaughlin J; Mølhave L; Fernandes EO; Seifert B
Allergy; 2008 Jul; 63(7):810-9. PubMed ID: 18588546
[TBL] [Abstract][Full Text] [Related]
35. Quo vadis? Cui bono? Quosque tandem?
Mohr U
Exp Toxicol Pathol; 2008 Jun; 60(2-3):101-3. PubMed ID: 18499415
[No Abstract] [Full Text] [Related]
36. The Seventh Amendment directive--an unnecessary measure to a necessary end--possible legal challenges to directive 2003/15/EC of the European Parliament and of the Council Amending Council Directive 76/768/EEC under European Union law.
Rosholt AP
Food Drug Law J; 2005; 60(3):421-46. PubMed ID: 16304747
[No Abstract] [Full Text] [Related]
37. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
[TBL] [Abstract][Full Text] [Related]
38. Is there an alternative?
Farrant A
Nurs Stand; 2003 Jul 2-8; 17(42):18-9. PubMed ID: 12874922
[No Abstract] [Full Text] [Related]
39. The system of mutual recognition of batch release in the EU--implications for combined vaccines.
Dobbelaer R
Biologicals; 1994 Dec; 22(4):377-80. PubMed ID: 7779364
[No Abstract] [Full Text] [Related]
40. Per aspirin ad astra..
Hartung T
Altern Lab Anim; 2009 Dec; 37 Suppl 2():45-7. PubMed ID: 20105011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
